Overexpression of C/EBP -LIP, a Naturally Occurring, Dominant-Negative Transcription Factor, in Human Breast Cancer
- 17 December 1997
- journal article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 89 (24), 1887-1891
- https://doi.org/10.1093/jnci/89.24.1887
Abstract
When cells fail to maintain a balance between proliferation, terminal differentiation, and programmed cell death, cancer often results. The CCAAT/enhancer-binding protein (C/EBP) family of transcription factors regulates many genes involved in the processes of proliferation and terminal differentiation. The messenger RNA for C/EBPbeta is translated into two major isoforms, LAP (liver-enriched activating protein) and LIP (liver-enriched inhibitory protein). LIP levels appear to be elevated in mouse mammary tumors but not in hyperplastic mammary tissues. We tested whether LIP expression is elevated in human breast cancer and whether elevated expression is associated with biologic predictors of the aggressiveness of the disease. Homogenates of infiltrating ductal carcinoma specimens from 39 women were analyzed for C/EBPbeta protein content by western blot analysis, and the ratio of LAP to LIP in specimens containing high levels of LIP (i.e., levels approximately 15 times higher than those in tumor specimens that express little or no LIP) was also determined. Nonparametric statistical analyses were performed. LIP was present at high levels in nine of 39 specimens of infiltrating ductal carcinoma. Eight of the nine specimens of infiltrating ductal carcinoma that contained high levels of LIP were negative for estrogen receptor and progesterone receptor (ER-/PR-); all nine tumors were aneuploid and poorly differentiated, and eight of nine were highly proliferative. Of the tumors that contained LIP at low or nondetectable levels, six of 30 were ER-/PR-, 17 of 29 were aneuploid, eight of 27 were highly proliferative, and 11 of 30 were poorly differentiated. LIP expression should be evaluated further as a prognostic marker for patients with breast cancer.This publication has 12 references indexed in Scilit:
- A Novel Human CCAAT/Enhancer Binding Protein Gene, C/EBPϵ, Is Expressed in Cells of Lymphoid and Myeloid Lineages and Is Localized on Chromosome 14q11.2 Close to the T-Cell Receptor α/δ LocusGenomics, 1996
- Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6.Proceedings of the National Academy of Sciences of the United States of America, 1996
- Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expressionMolecular Endocrinology, 1995
- Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerizationTrends in Biochemical Sciences, 1991
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the sam mRNACell, 1991
- Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells.Genes & Development, 1991
- A genetic model for colorectal tumorigenesisCell, 1990
- Scissors-Grip Model for DNA Recognition by a Family of Leucine Zipper ProteinsScience, 1989
- Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variablesThe Journal of Pathology, 1987